Lessons learned from AACR24 – Part 1
Sunny San Diego is full of surprises
The AACR annual meeting is an opportunity to challenge established paradigms and scientific dogma.
In this post, we’re highlighting some key learnings we’ve taken from the conference in San Diego, which others in oncology new product development might well want to think about.
Agree or disagree, part of what we do at BSB is challenge your thinking, and consider what we can learn, both good and bad, from researchers, industry executives, thought leaders, and regulatory agencies.
There’s certainly been a lot of inspiring science on show at AACR24 and we’ll have more of those learnings to share in part 2.
To learn more from our latest oncology expert interview and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers
